3SBio Inc. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
806
523
2,306
1,173
3,741
2,138
Total Accounts Receivable
294
500
794
949
2,051
2,442
Inventories
65
125
160
293
452
439
Other Current Assets
22
27
37
76
80
32
Total Current Assets
1,186
1,175
3,298
2,491
6,324
5,050
Net Property, Plant & Equipment
322
469
553
2,009
2,151
2,118
Total Investments and Advances
5
294
2,064
151
98
800
Long-Term Note Receivable
17
22
-
89
42
33
Intangible Assets
54
795
1,263
7,156
7,415
7,284
Other Assets
35
113
717
345
387
401
Total Assets
1,624
2,883
7,913
12,315
16,510
15,782
ST Debt & Current Portion LT Debt
-
772
483
578
1,305
Accounts Payable
9
32
41
66
330
Income Tax Payable
2
5
12
44
133
Other Current Liabilities
104
756
385
588
867
Total Current Liabilities
115
1,565
922
1,276
2,636
Long-Term Debt
-
-
-
2,834
4,040
Deferred Taxes
78
78
79
255
245
Other Liabilities
15
47
21
27
22
Total Liabilities
213
1,704
1,041
4,465
7,035
Common Equity (Total)
1,371
1,165
6,713
7,277
8,823
Total Shareholders' Equity
1,371
1,165
6,713
7,277
8,823
Total Equity
1,386
1,179
6,726
7,549
9,102
Liabilities & Shareholders' Equity
1,624
2,883
7,913
12,315
16,510
Accumulated Minority Interest
14
14
13
272
280
Non-Equity Reserves
26
-
146
301
373

About 3SBio

View Profile
Address
Shenyang Economy & Tech Development
Shenyang Liaoning 110027
China
Employees -
Website http://www.3sbio.com
Updated 07/08/2019
3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products. It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.